跳至主要内容
临床试验/NCT00808808
NCT00808808已完成不适用

Assessing Choice in the Employer Setting (ACES Study): An Observational Study to Assess the Impact of Offering Intranasal Vaccine on Influenza Vaccination Rates in the Employer Setting

MedImmune LLC0 个研究点目标入组 4,411 人开始时间: 2008年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
MedImmune LLC
入组人数
4,411
主要终点
Overall Vaccination Rate, All Ages

研究概览

简要总结

The purpose of this study is to determine, among adults and in the total population, the effects of offering a choice of FluMist or trivalent inactivated vaccine (TIV) in the employer setting when compared to a control group.

详细描述

The primary objective is to determine, among adults in the 18-49 year old population and in the total population, the effects of offering a choice of FluMist or TIV with and without enhanced advertisement/added incentive on the overall influenza vaccination rates in the employer setting when compared to a control group.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Overall Vaccination Rate, All Ages

时间窗: 30Sep2008 through 23Dec2008

Overall Vaccination Rate, Employees 18 to 49 Years of Age

时间窗: 30Sep2008 through 23Dec2008

次要结局

  • Change in Influenza Vaccination Rate From Baseline Season to Intervention Season in the Total Population(2007-2008 season through 2008-2009 season)
  • Change in Influenza Vaccination Rate From Baseline Season to Intervention Season in Employees 18-49 Years of Age(2007-2008 season through 2008-2009 season)
  • Percent of Eligible Participants 18-49 Years of Age Choosing FluMist During Intervention Season(30Sep2008 through 23Dec2008)
  • Characteristics of Participants 18-49 Years of Age Choosing FluMist vs TIV: Race(30Sep2008 through 23Dec2008)
  • Characteristics of Participants 18-49 Years of Age Choosing FluMist vs TIV: Education(30Sep2008 through 23Dec2008)
  • Characteristics of Participants 18-49 Years of Age Choosing FluMist vs TIV: Gender(30Sep2008 through 23Dec2008)

研究者

发起方
MedImmune LLC
申办方类型
Industry

相似试验